Veraxa Biotech Holding AG
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Veraxa Biotech Holding AG is publicly traded on NASDAQ under the ticker VRXA.
Veraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical...
Can you invest in Veraxa Biotech Holding AG?
Yes. Veraxa Biotech Holding AG trades publicly on NASDAQ as VRXA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Veraxa Biotech Holding AG
Detailed equity research is provided by MarketSnap.